Transactions of the annual meeting of the american gynecological and obstetrical societyManipulation of the pill-free interval in oral contraceptive pill users: the effect on follicular suppression☆
Section snippets
Study design
This randomized, investigator-blinded study was approved by the Colorado Multiple Institutional Review Board. Subjects were recruited between July 2000 and March 2002 by broadcast e-mail messages on the University of Colorado Health Sciences Center campus and print advertising. Interested women were screened for eligibility by telephone call to a study co-ordinator. Subjects were required to be between 18 and 38 years old and to report a history of regular menstrual periods at 28 ± 5-day
Results
Fifty-four women were assigned randomly to 1 of the 3 groups. One woman became pregnant before starting the study drug, and 8 women elected not to continue in the study during their first month of OCP treatment for a variety of personal reasons. The baseline characteristics of the 45 remaining women are shown in Table I. Women in the continuous group were older than women in the other 2 groups (P = .01), although the mean age was still only 31.4 years. There was no difference in the mean BMI
Comment
Our data demonstrate that manipulation of the traditional pill-free interval affects folliculogenesis in users of the common 20-μg EE combination OCPs. Women who were supplemented with 5 days of 10 μg EE had fewer and smaller follicles than woman who had a 7-day pill-free interval. In turn, women who were treated with 7 days of 20 μg EE plus 150 μg desogestrel had even fewer and smaller follicles. The obvious concern resulting from these observations is that women who have a 7-day pill-free
Acknowledgments
We thank Dr James R. Murphy for statistical consultation.
References (30)
- et al.
Activity of the pituitary-ovarian axis in the pill-free interval during use of low-dose combined oral contraceptives
Contraception
(1999) - et al.
The effect of extending the pill-free interval on follicular activity: triphasic norgestimate/35 μg ethinyl estradiol versus monophasic levonorgestrel/20 μg ethinyl estradiol
Contraception
(2002) - et al.
Omitting the first oral contraceptive pills of the cycle does not automatically lead to ovulation
Am J Obstet Gynecol
(1998) - et al.
Extending the duration of active oral contraceptive pills to manage hormone withdrawal symptoms
Obstet Gynecol
(1997) - et al.
Oral contraceptive type and functional ovarian cysts
Am J Obstet Gynecol
(1992) - et al.
Longitudinal ultrasonographic study of the ovarian suppressive activity of a low-dose triphasic oral contraceptive during correct and incorrect pill intake
Am J Obstet Gynecol
(1989) - et al.
Shorter pill-free interval in combined oral contraceptives decreases follicular development
Contraception
(1996) - et al.
Ovarian activity in women taking an oral contraceptive containing 20 μg ethinyl estradiol and 150 μg desogestrel: effects of low estrogen doses during the hormone-free interval
Am J Obstet Gynecol
(1998) - et al.
Acceptance of altering the standard 21-day/7-day oral contraceptive regimen to delay menses and reduce hormone withdrawal symptoms
Am J Obstet Gynecol
(2002) - et al.
Menstrual reduction with extended use of combination oral contraceptive pills: randomized controlled trial
Obstet Gynecol
(2001)
Continuous combination oral contraceptive pills to eliminate withdrawal bleeding: a randomized trial
Obstet Gynecol
Growth patterns of nondominant ovarian follicles during the normal menstrual cycle
Fertil Steril
Decremental follicle-stimulating hormone and dominant follicle development during the normal menstrual cycle
Fertil Steril
Follicle-stimulating hormone and advanced follicle development in the human
Arch Med Res
Differences in hormonal characteristics of conceptive versus nonconceptive menstrual cycles
Fertil Steril
Cited by (104)
Ovarian function during hormonal contraception assessed by endocrine and sonographic markers: a systematic review
2016, Reproductive BioMedicine OnlineCitation Excerpt :The continuous LNG + EE regimen (28 days for 3 cycles) completely suppressed ovulation, with poor follicular growth documented by ultrasound and with fast recovery of ovulation after interrupting COC use (Archer et al., 2009). Three randomized studies (Schlaff et al., 2004; Seidman et al., 2015; Vandever et al., 2008) and one prospective study (Kroll et al., 2015) evaluated the suppression of ovarian function after the supplementation of EE during HFI. In 2004, Schlaff et al. randomly assigned 54 women to receive one of these three different regimens: either 20 µg EE + 100 µg LNG followed by seven pill-free days, or 20 µg EE + 150 µg DSG followed by 2 days of placebo then 10 µg EE for 5 days, or 28 days of 20 µg EE + 150 µg DSG.
Rationale for eliminating the hormone-free interval in modern oral contraceptives
2016, International Journal of Gynecology and ObstetricsOvulatory effects of three oral contraceptive regimens: A randomized, open-label, descriptive trial
2015, ContraceptionCitation Excerpt :Shortening the HFI may increase the efficacy of low-estrogen-dose contraceptive regimens [4,8,11,12]. Alternatively, the addition of low-dose estrogen during the usual 7-day HFI has produced greater ovarian suppression, less risk of escape ovulation and improvements in hormone-related symptoms and breakthrough bleeding, and has been shown to be safe and efficacious [8,13,14]. The current study examined ovulation inhibition and ovarian activity in a 21/7-active COC regimen of 150 mcg desogestrel (DSG)/20 mcg EE followed by 7 days of 10 mcg EE.
- ☆
Presented at the Twenty-Second Annual Meeting of the American Gynecological and Obstetrical Society, Napa, California, September 18-20, 2003.
Supported in part by an investigator-initiated grant from Organon, Inc, West Orange, NJ.